NRD
FLGT icon

Nebula Research & Development’s Fulgent Genetics FLGT Stock Holding History

Nebula Research & Development’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37,902
Closed -$753K – 338
2025
Q2 		$753K Buy
37,902
+2,550
+7% +$49.7K 0.06% 504
2025
Q1 		$597K Buy
35,352
+2,392
+7% +$40.7K 0.06% 556
2024
Q4 		$609K Buy
+32,960
New +$643K 0.07% 483
2024
Q3 		– Sell
-17,147
Closed -$336K – 1012
2024
Q2 		$336K Sell
17,147
-6,787
-28% -$142K 0.05% 570
2024
Q1 		$519K Buy
+23,934
New +$594K 0.11% 342
2023
Q3 		– Sell
-10,382
Closed -$384K – 554
2023
Q2 		$384K Buy
+10,382
New +$362K 0.29% 178

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nebula Research & Development's FLGT Position: Q3 2025 in Review

Nebula Research & Development sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 37,902 shares — an estimated $753K sold.

Nebula Research & Development first reported a position in FLGT in Q2 2023 and held it in 6 quarters. The position peaked at $753K in Q2 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Nebula Research & Development reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 37,902 Fulgent Genetics shares in Q3 2025, an estimated $753K.
  • Nebula Research & Development first reported a position in Fulgent Genetics in Q2 2023 and held it in 6 quarters.
  • Nebula Research & Development's Fulgent Genetics position peaked at $753K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.